Faruqi Firm Files Antitrust Case Over ADHD Medication


On January 11, 2017, Faruqi & Faruqi, LLP filed a federal antitrust class action case against brand and generic manufacturers of ADHD drug, Intuniv.  The complaint alleges that the companies, Shire and Actavis, violated the antitrust laws by entering into an anticompetitive agreement that delayed generic competition for Intuniv.  Under the agreement, Shire effectively paid Actavis tens of millions of dollars to delay launching a generic version of Intuniv.  As a result, purchasers of Intuniv were forced to pay higher prices for the drug.  The case was filed in the United States District Court for the District of Massachusetts and is captioned as follows: Rochester Drug Co-Operative Inc. v. Shire LLC et al., Case No. 1:17-cv-10050.

Finding us

Our Offices


Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

1901 Avenue of the Stars Suite 1060
Los Angeles, California 90067
(424) 256-2884
(424) 256-2885

Georgia

3565 Piedmont Road NE Building Four, Suite 380
Atlanta, Georgia 30305
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania